Drugs / isoflavones
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT00051402 | Dec 2002 → Aug 2007 | amnestic disorder | National Center for Complementary and Integrative Health (NCCIH) | Completed | No outcome recorded |
| Phase not applicable1 trial · 1 missed | ||||||
| — | NCT00861588 | Feb 2006 → Sep 2007 | benign prostatic hyperplasia | Chinese University of Hong Kong | Completed | Missed primary |
| Comparator or background therapy1 trial | ||||||
| — | NCT01377961 Comparator | Sep 2010 → Aug 2015 | metabolic syndrome X, type 2 diabetes mellitus | The University of Texas Medical Branch, Galveston | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Isoflavones | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00051402 ↗ |
| Route | Oral | “participants will take the supplement pill or placebo three times a day” NCT00051402 ↗ |